Tepotinib
3-[1-[[3-[5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl]phenyl]methyl]-6-oxopyridazin-3-yl]benzonitrile
Molecular Identity
Tepotinib
3-[1-[[3-[5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl]phenyl]methyl]-6-oxopyridazin-3-yl]benzonitrile
PubChem CID: 25171648
2D Structure
Properties
C29H28N6O2
Molecular Formula
492.60
Molecular Weight
g/mol
492.2274
Exact Mass
Da
3.4
XLogP
Drug-like (Lipinski: < 5)
94.7
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
7
H-Bond Acceptors
880
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Tepotinib1100598-32-0EMD-1214063EMD 1214063EMD1214063MSC-2156119JMSC2156119JMSC2156119MSC-21561191IJV77EI07DTXSID70149132Benzonitrile, 3-(1,6-dihydro-1-((3-(5-((1-methyl-4-piperidinyl)methoxy)-2-pyrimidinyl)phenyl)methyl)-6-oxo-3-pyridazinyl)-Benzonitrile, 3-[1,6-dihydro-1-[[3-[5-[(1-methyl-4-piperidinyl)methoxy]-2-pyrimidinyl]phenyl]methyl]-6-oxo-3-pyridazinyl]-3-{1-[(3-{5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl}phenyl)methyl]-6-oxo-1,6-dihydropyridazin-3-yl}benzonitriletepotinibum
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Tepotinib
Loading drug network...